Enhancing cancer care through genomic testing
Simon Holt, Honorary Professor at Swansea University, reflects on the key challenges within cancer care and the benefits of genomic testing in improving patient outcomes.
Consuming ultra-processed foods associated with elevated cancers
Consuming higher-quality ultra-processed foods (UPFs) might be linked to a higher risk of cancers in the upper aerodigestive tract, encompassing the mouth, throat, and oesophagus.
Identifying lung cancer risk in ‘never smokers’ using artificial intelligence
An artificial intelligence tool can effectively detect high-risk individuals for lung cancer among non-smokers using routine chest X-ray images.
Breast cancer drug made accessible to 289,000 women in England
Anastrozole is to be made accessible to postmenopausal women who have a family history of breast cancer to help prevent the disease
Rapid cell production for cancer treatment achieved by new machine
A new method for quickly growing cancer-killing white blood cells can potentially enhance the accessibility of immunotherapy.
Cutting-edge robot holds promise for early breast cancer diagnosis
A ground breaking breast lump detection merging CBE with AI and sensors, has the potential to enhancing diagnostic methods like ultrasound.
Cracking the genetic code of a rare kidney cancer
In a groundbreaking study, researchers have decoded the genetic makeup of a rare kidney cancer known as reninoma.
AI’s potential in predicting esophageal and stomach Cancer
For fifty years, Western nations have faced a rising wave of lethal esophageal and stomach cancer. AI's predictive capability in these cancers is now evident.
The impact of weight loss surgery on Cancer prevention
New research reveals that weight loss surgery is linked to reduced cancer incidence and mortality, particularly among females.
Impact of assisted suicide on Cancer-related deaths
A study in Cancer Medicine examines trends in self-initiated deaths among cancer patients in Switzerland over 20 years, comparing assisted suicide.
How can AI oncology diagnostics help the NHS?
DeepMed has developed an AI oncology diagnostics system, DeepPathTM - LYDIA, to assist histopathologists in performing lymph node metastasis detection quickly and accurately.
Nutrition research for acute childhood leukaemia
Dr Zisis Kozlakidis explores the value of nutrition in acute childhood leukaemia diagnosis and treatment.
Photodynamic Therapy: Killing cancer gently with visible light
Photodynamic therapy, using visible light with lower energy, causes fewer side effects when treating cancer, find Drs. Mary Potasek, Evgueni Parilov, and Karl Beeson, Co-founders of Simphotek, Inc.
Breast cancer survival rate sees a 66% improvement over 20 years
Women with early stage breast cancer today are 66% less likely to die within five years of diagnosis than they were in the 1990s, research on the breast cancer survival rate finds.
Following cancer prevention recommendations reduces risk of the disease
Following global cancer prevention recommendations reduces the risk of developing the disease according to latest study.
Universal receptor system allows customizable immunotherapies for cancer
A universal receptor system that enables T cells to recognize any cell surface target has been created by University of Pittsburgh researchers, which could revolutionise customizable immunotherapies for treating cancer and other diseases.
How AI can optimise early cancer treatment
Early cancer treatment is vital to sustaining high cancer survival rates, but could AI improve clinician capabilities and predict worse cases?
Improving cancer therapy using sonoenhancement with acoustic cluster therapy
Sonoenhancement with Acoustic Cluster Therapy (ACT®) improves drug delivery to solid tumors, and by that reduces the necessary doses and side effects.
Can neurodevelopmental disorders affect testicular cancer occurrence?
Research finds that men who have a neurodevelopmental disorder, such as autism and ADHD, also have a slightly increased risk of testicular cancer.
Can AI be used to predict and prevent breast cancer?
Lester Litchfield, Head of Data Science at Volpara Health, discusses the future of artificial intelligence in breast health.